Migliorare le linee guida del consenso informato

i-CONSENT, finanziato dal programma Horizon 2020 dell’Unione Europea, ha lo scopo di migliorare il modo in cui i pazienti ricevono le informazioni dagli studi clinici. All’interno del progetto, verranno create una serie di linee guida per migliorare il processo del consenso informato, includendo le popolazioni vulnerabili, da una prospettiva di gender e basandosi sulle tecnologie ICT.

Il Progetto

Project guidelines now available!

Mar 25, 2021

The i-CONSENT Project publishes its final product: "Guidelines for tailoring the informed consent process in clinical studies" Fragment of the guidelines. The i-CONSENT Guidelines are now ready and available for academia, clinical investigators, pharmaceutical...

leggi tutto
View All
Visit our Twitter and get the latest content!
@ICONSENTEU

i-CONSENTFollow

H2020 project aimed to improve #informedconsent by focusing on gender, age and vulnerable populations to promote patient autonomy and empowerment through TIC.

Avatar
Retweet on Twitteri-CONSENT Retweeted
AvatarUNESCOBIOCHAIR@unescobiochair·
22 Nov

#NewPublication | "Cross-Cultural and Religious Critiques of Informed Consent" edited by Joseph Tham, Alberto García Gómez, Mirko Daniel Garasic.
@agarciago
@MDGarasic
@ICONSENTEU
#InformedConsent

Read more: http://bit.ly/2tWUyTE

Reply on Twitter 1462773031483359232Retweet on Twitter 14627730314833592323Like on Twitter 14627730314833592328Twitter 1462773031483359232
Load More...

i-CONSENT in Numbers

Dal 2017 al 2020

Partners

milioni di finanziamenti europei

paesi

Durata 3 anni

Multimedia

 i-CONSENT falls under the ‘Science with and for Society’ (SWAFS) programme, which means that on of our main goals is unlocking science for use by the wider public. i-CONSENT is committed to improving citizens’ health literacy not only as a solution to make science more attractive to them but also as a way of empowering them. This section will offer visitors and stakeholders information on the project, in particular, and  knowledge on clinical trials, research and ethics, in general.